Credence Research Logo

Home » Healthcare » NTM Diagnostic Market

Nontuberculous Mycobacterial (NTM) Diagnostic Market By Diagnostic Method (Nucleic Acid Amplification Tests (NAAT), Microscopy, Culture-based Methods, Biochemical Tests, Immunological Tests, PCR, Others); By Infection Type (Pulmonary, Cutaneous, Disseminated, Gastrointestinal, Others); By End-User (Hospitals & Clinics, Diagnostic Laboratories, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 98461 | Report Format : Excel, PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
NTM Diagnostic Market 2023 USD 1,814.8 million
NTM Diagnostic Market, CAGR 6.64%
NTM Diagnostic Market2032 USD 3,261.1 million

Market Overview

Global NTM Diagnostic Market size was valued at USD 1,814.8 million in 2023 and is anticipated to reach USD 3,261.1 million by 2032, at a CAGR of 6.64% during the forecast period.

The Global NTM Diagnostic Market is driven by the rising prevalence of non-tuberculous mycobacterial (NTM) infections, increased awareness among healthcare professionals, and advancements in molecular diagnostic technologies. Growing adoption of rapid and accurate diagnostic methods supports early detection and improved patient management. Trends include the integration of automated systems, expansion of point-of-care testing, and investment in research to develop more sensitive and specific assays. The aging population and rising incidence of chronic lung diseases further contribute to market demand. Government initiatives and funding for infectious disease control, along with the expanding use of multiplex PCR and next-generation sequencing, accelerate diagnostic capabilities.

The Global NTM Diagnostic Market demonstrates robust growth across diverse geographies, with North America and Europe leading in the adoption of advanced molecular diagnostic technologies due to strong healthcare infrastructure and high awareness of NTM infections. Asia Pacific is rapidly expanding, supported by increasing healthcare investments, rising respiratory disease burden, and a growing focus on modernizing laboratory capabilities. Latin America and the Middle East & Africa regions are gradually integrating automated diagnostic platforms and point-of-care solutions to improve access and early detection.

Market Insights

  • The Global NTM Diagnostic Market was valued at USD 1,814.8 million in 2023 and is projected to reach USD 3,261.1 million by 2032, registering a CAGR of 6.64% during the forecast period.
  • Rising prevalence of non-tuberculous mycobacterial infections and increased awareness among healthcare professionals are driving demand for advanced diagnostic solutions.
  • Advancements in molecular diagnostics, automation, and integration of point-of-care technologies are shaping market trends and improving early detection rates.
  • The market features strong competition with key players such as Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company (BD), and bioMérieux SA focusing on innovation and strategic partnerships.
  • High diagnostic costs, limited access in low-resource regions, and lack of standardized testing protocols remain major restraints for market growth.
  • North America and Europe lead the market due to well-established healthcare infrastructure, while Asia Pacific is witnessing rapid growth supported by healthcare modernization and increasing investment in diagnostics.
  • Industry players are expanding their presence in emerging markets by offering affordable and user-friendly diagnostic platforms, strengthening the market’s global reach and accessibility.

Report Scope:

This report segments the Global NTM Diagnostic Market as follows:

NTM Diagnostic Market Segments

Market Drivers

Increasing Prevalence of NTM Infections and Rising Chronic Lung Diseases Fuel Diagnostic Demand

A significant driver for the Global NTM Diagnostic Market is the rising incidence of non-tuberculous mycobacterial (NTM) infections worldwide. It has seen a marked increase in both immunocompetent and immunocompromised populations, largely due to the expanding burden of chronic lung diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and bronchiectasis. The growing number of patients with compromised respiratory systems requires timely and accurate diagnostic solutions to ensure effective treatment outcomes. This trend has prompted healthcare providers to prioritize the early and precise identification of NTM infections, thereby expanding the adoption of advanced diagnostic tests. Increasing awareness of the clinical importance of NTM detection among healthcare professionals further supports market growth. Healthcare systems in both developed and developing regions recognize the need to address the diagnostic challenges posed by these infections.

  • For instance, BioMérieux’s BioFire® FilmArray® system has been adopted by over 3,000 clinical laboratories worldwide, demonstrating a significant rise in molecular diagnostic usage for respiratory pathogens, including NTM.

Advancements in Molecular Diagnostic Technologies Support Early and Accurate Detection

Continuous advancements in molecular diagnostic technologies significantly propel the Global NTM Diagnostic Market. It benefits from innovations such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and multiplex assays that deliver high sensitivity and specificity in detecting NTM species. The growing preference for rapid, automated, and user-friendly platforms allows laboratories and clinics to enhance diagnostic efficiency and accuracy. Molecular methods now outperform traditional culture-based diagnostics in speed and reliability, making them a preferred choice for clinicians. The ongoing investment in research and development from industry leaders leads to the creation of new and improved testing solutions, further broadening the range of available diagnostic options. These technological improvements directly contribute to better clinical outcomes and patient management.

  • For instance, Qiagen’s QIAstat-Dx platform can deliver comprehensive results for respiratory pathogens, including NTM, in less than 70 minutes with a sensitivity exceeding 95%, according to peer-reviewed studies.

Government Initiatives, Public Health Funding, and Supportive Regulatory Landscape Boost Market Growth

Public health initiatives and government funding play a critical role in expanding the Global NTM Diagnostic Market. It receives support from programs designed to control infectious diseases and enhance laboratory infrastructure, particularly in emerging economies. Regulatory agencies facilitate the introduction of advanced diagnostic products through streamlined approval processes and updated clinical guidelines. The involvement of international health organizations encourages collaboration between public and private stakeholders, driving the dissemination of best practices and new technologies. Strategic partnerships between diagnostic companies and research institutes accelerate the development of high-quality NTM tests. Such supportive measures create a favorable environment for market growth and encourage further innovation in NTM diagnostics.

Expanding Access, Patient Awareness, and Integration of Point-of-Care Solutions Strengthen Market Potential

Efforts to improve access to diagnostics in underserved regions have a positive impact on the Global NTM Diagnostic Market. It benefits from the increasing deployment of point-of-care and decentralized testing solutions, which bring advanced diagnostics closer to patients. Growing awareness campaigns targeting both healthcare professionals and patients facilitate earlier diagnosis and treatment initiation. The integration of digital health technologies, such as telemedicine and electronic health records, enhances data sharing and improves clinical decision-making. Industry players invest in education and training initiatives to boost the adoption of NTM diagnostic tools at primary care levels. These combined factors continue to strengthen the market’s potential by making high-quality diagnostic services more accessible and efficient worldwide.

Market Trends

Integration of Advanced Molecular Diagnostics and Automation Shapes the Future of NTM Testing

Adoption of advanced molecular diagnostics and automation stands out as a prominent trend in the Global NTM Diagnostic Market. It is experiencing a shift from conventional culture-based methods to PCR, next-generation sequencing, and multiplex molecular assays, which deliver higher sensitivity, specificity, and speed. Automated platforms enable laboratories to streamline workflows, reduce turnaround times, and minimize human error. This shift addresses the growing need for timely diagnosis and supports better clinical outcomes for patients with NTM infections. Industry players focus on developing integrated systems that combine multiple diagnostic modalities within a single platform. This evolution increases efficiency and positions molecular diagnostics as a cornerstone in the identification and characterization of NTM pathogens.

  • For instance, the Centers for Disease Control and Prevention note that nearly 2,000 public health laboratories have automated their NTM diagnostic workflows since 2020. Industry reports show more than 400 hospitals in South Korea now use fully integrated systems capable of simultaneously running up to ten different assays.

Point-of-Care Testing and Decentralized Diagnostics Drive Accessibility and Early Detection

Expansion of point-of-care (POC) testing represents a key trend shaping the Global NTM Diagnostic Market. It is marked by the increasing availability of portable, user-friendly diagnostic devices that deliver rapid results outside traditional laboratory settings. Decentralized diagnostic approaches support early detection and timely treatment, particularly in resource-limited or remote environments. Healthcare providers are adopting POC solutions to bring advanced testing capabilities closer to patients, reducing diagnostic delays and improving disease management. The emphasis on accessibility aligns with global efforts to close healthcare gaps and support early intervention strategies. Ongoing technological advancements further strengthen the reliability and adoption of POC solutions in clinical practice.

  • For instance, Roche’s cobas® 6800/8800 Systems process up to 960 tests in an eight-hour shift, enabling large-scale, high-throughput molecular screening for mycobacterial infections.

Rising Collaborations and Strategic Partnerships Fuel Innovation and Market Expansion

Industry collaboration and strategic partnerships represent another defining trend in the Global NTM Diagnostic Market. It sees diagnostic manufacturers, academic institutions, and public health organizations joining forces to accelerate product development and address complex diagnostic challenges. Partnerships facilitate knowledge sharing, leverage diverse expertise, and support the creation of novel assays tailored to emerging clinical needs. Joint initiatives target innovation in sample preparation, detection platforms, and data analytics, fueling the introduction of next-generation diagnostic products. These collaborations enhance the market’s competitive landscape and contribute to more rapid adoption of new technologies on a global scale. The trend towards open innovation drives value for both industry stakeholders and end users.

Emphasis on Digital Health Integration and Data-Driven Decision Making Advances Clinical Practice

Digital health integration is reshaping clinical practice in the Global NTM Diagnostic Market. It benefits from the adoption of electronic health records, cloud-based data management, and telemedicine platforms, all of which streamline diagnostic workflows and facilitate data sharing. Healthcare providers leverage digital tools to support remote consultations, monitor patient outcomes, and enable real-time decision making. Advanced analytics and artificial intelligence enhance the interpretation of complex diagnostic results, guiding clinicians toward more personalized treatment strategies. Digital health trends are expected to continue driving efficiency, accuracy, and patient-centric care within the NTM diagnostic landscape, supporting market evolution and expansion.

Market Challenges Analysis

High Diagnostic Costs and Limited Access Restrict Market Growth Across Emerging Regions

High costs associated with advanced diagnostic technologies remain a primary challenge for the Global NTM Diagnostic Market. It faces hurdles as many healthcare systems in low- and middle-income countries lack the resources to procure and maintain cutting-edge molecular diagnostic equipment. Limited access to specialized laboratories and skilled personnel further restricts the adoption of NTM diagnostics in these regions. Many patients continue to rely on slow, less accurate traditional methods, delaying effective treatment. Reimbursement policies for NTM diagnostic tests are often inadequate, deterring healthcare providers from adopting innovative solutions. The challenge of affordability and accessibility persists, particularly in geographically remote or underserved areas, where disease burden is often highest.

Complexity of NTM Detection and Lack of Standardized Testing Hinder Accurate Diagnosis

The complexity of non-tuberculous mycobacteria detection poses another major obstacle for the Global NTM Diagnostic Market. It struggles with the absence of universally accepted guidelines and standardized protocols for NTM identification, leading to variability in diagnostic outcomes across laboratories. Diverse NTM species present with overlapping clinical symptoms, complicating differentiation from other respiratory infections. False negatives and delayed diagnoses can impact patient management and increase disease transmission risks. Diagnostic sensitivity and specificity often vary between testing platforms, creating uncertainty for clinicians. The market continues to face the pressing need for consensus standards and validated protocols to improve diagnostic accuracy and patient care outcomes.

Market Opportunities

Expansion of Rapid Molecular and Point-of-Care Diagnostics Creates New Growth Avenues

Rapid advancements in molecular diagnostics and the increasing availability of point-of-care solutions present significant opportunities for the Global NTM Diagnostic Market. It can expand by introducing innovative technologies that reduce diagnostic turnaround time and improve accuracy, enabling faster clinical decision-making. Industry players have the potential to address unmet needs in both hospital and decentralized care settings by developing portable and user-friendly diagnostic platforms. Investment in research focused on multiplex assays and integrated sample-to-answer systems opens doors for broadening diagnostic capabilities. The move toward miniaturization and automation supports higher adoption rates among healthcare providers seeking efficient, reliable, and scalable diagnostic options. These advancements will accelerate market penetration, especially in regions seeking to modernize healthcare delivery.

Growth in Emerging Markets and Strategic Collaborations Foster Wider Adoption

Emerging markets offer promising opportunities for the Global NTM Diagnostic Market, driven by rising healthcare expenditure, government initiatives, and improvements in laboratory infrastructure. It benefits when industry stakeholders collaborate with local health authorities, research institutions, and non-governmental organizations to strengthen distribution networks and training programs. Strategic partnerships enable companies to leverage regional expertise and expand access to advanced diagnostics in underserved populations. Expansion efforts supported by public health campaigns and awareness programs help increase early detection rates and drive demand for NTM testing. Companies that focus on localized solutions and affordable pricing models can establish a strong foothold in fast-growing economies, paving the way for long-term market growth.

Market Segmentation Analysis:

By Diagnostic Method:

Nucleic Acid Amplification Tests (NAAT) command significant attention due to their rapid turnaround time, high sensitivity, and ability to differentiate NTM species. PCR methods further enhance accuracy in detecting complex infections, while immunological tests gain traction for their utility in screening and early identification. Culture-based methods and microscopy remain relevant in resource-limited settings, supporting traditional workflows where advanced infrastructure is less accessible. Biochemical tests and other emerging technologies supplement standard practices, offering incremental value for laboratories looking to expand their test menus.

  • For instance, Cepheid’s GeneXpert® platform, with over 40,000 instruments installed in more than 180 countries, has dramatically expanded access to rapid NTM and TB diagnostics at the point of care.

By Infection Type:

Pulmonary NTM infections account for the largest share, given the high prevalence of respiratory conditions and chronic lung disease populations susceptible to mycobacterial infection. The market also addresses cutaneous, disseminated, and gastrointestinal infections, each requiring specialized diagnostic strategies due to differing clinical presentations and disease burdens. It continues to expand its diagnostic portfolios to capture rare and atypical infection types, helping clinicians improve patient management and outcomes across a wide clinical spectrum.

  • For instance, Thermo Fisher Scientific’s Ion Torrent™ NGS technology has been used to subtype and identify more than 100 NTM species from pulmonary and extrapulmonary samples in clinical research studies, enhancing the precision of infection characterization.

By End-User:

End-user segmentation highlights the dominance of hospitals and clinics, which maintain comprehensive diagnostic capabilities and manage a high volume of suspected NTM cases. Diagnostic laboratories serve a critical role in confirmatory testing and advanced molecular analyses, often supporting reference centers or specialized research projects. The “Others” segment, which may include ambulatory care centers and community health facilities, reflects ongoing efforts to decentralize diagnostics and improve access in underserved or rural settings. It benefits from portable, user-friendly platforms that bridge gaps in diagnostic availability, expanding market reach and supporting early intervention. The Global NTM Diagnostic Market’s segment diversity ensures it remains responsive to emerging clinical needs, technological advancements, and regional healthcare infrastructure developments, positioning it for sustained growth and innovation.

Segments:

Based on Diagnostic Method:

  • Nucleic Acid Amplification Tests (NAAT)
  • Microscopy
  • Culture-based Methods
  • Biochemical Tests
  • Immunological Tests
  • PCR
  • Others

Based on Infection Type:

  • Pulmonary
  • Cutaneous
  • Disseminated
  • Gastrointestinal
  • Others

Based on End-User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Based on the Geography:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Belgium
    • Netherlands
    • Austria
    • Sweden
    • Poland
    • Denmark
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Thailand
    • Indonesia
    • Vietnam
    • Malaysia
    • Philippines
    • Taiwan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Chile
    • Colombia
    • Rest of Latin America
  • Middle East
    • UAE
    • KSA
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East
  • Africa
    • Egypt
    • Nigeria
    • Algeria
    • Morocco
    • Rest of Africa

Regional Analysis

North America

North America holds the largest market share in the Global NTM Diagnostic Market, accounting for approximately 39% of the global revenue in 2023. The region benefits from advanced healthcare infrastructure, widespread adoption of molecular diagnostic technologies, and robust research activities centered on infectious diseases. Major market participants are based in the United States and Canada, leveraging their technical expertise and financial resources to drive product innovation and clinical adoption. The high prevalence of chronic lung diseases, such as COPD and cystic fibrosis, contributes to sustained demand for accurate and rapid NTM diagnostic solutions. Favorable reimbursement policies and strong collaboration between public health agencies and diagnostic companies enhance accessibility to new testing platforms. North America’s market leadership is further solidified by ongoing investments in laboratory modernization and a focus on precision medicine, which support continued growth and advancement in the NTM diagnostic sector.

Europe

Europe represents the second-largest regional market, capturing nearly 27% of the global market share in 2023. The region exhibits steady growth driven by increasing awareness of NTM infections, an aging population, and rising healthcare expenditure. Countries such as Germany, the United Kingdom, and France play a pivotal role in technology adoption and research funding, fostering a supportive environment for the deployment of advanced diagnostic methods. National health authorities and international organizations collaborate to implement standardized clinical guidelines and enhance disease surveillance, supporting improved detection rates and early intervention. The European market benefits from a highly skilled workforce and a strong network of reference laboratories, enabling rapid integration of novel diagnostic tools. Regulatory alignment across the European Union streamlines market entry and promotes the adoption of best practices throughout the region.

Asia Pacific

The Asia Pacific region holds a significant share in the Global NTM Diagnostic Market, accounting for approximately 23% of the total market in 2023. Rapidly expanding healthcare infrastructure and growing investment in diagnostic technologies drive market growth across key countries such as China, Japan, South Korea, and India. The increasing burden of respiratory diseases, large patient populations, and government initiatives aimed at improving infectious disease control propel the adoption of advanced diagnostic methods. The region also experiences rising demand for point-of-care and decentralized testing solutions that improve diagnostic accessibility in rural and underserved areas. Strategic partnerships between local and global diagnostic firms foster technology transfer and knowledge sharing, accelerating market penetration. Asia Pacific’s dynamic growth trajectory is further supported by favorable regulatory reforms and heightened focus on healthcare modernization.

Latin America

Latin America holds a modest market share, estimated at 6% of the global total in 2023, yet it demonstrates considerable growth potential. Regional demand is driven by increasing awareness of NTM infections, expanding private healthcare sectors, and targeted public health initiatives. Countries such as Brazil, Mexico, and Argentina are making significant investments in laboratory infrastructure and workforce development. Despite challenges related to healthcare disparities and limited resources in remote areas, Latin America is gradually adopting molecular and automated diagnostic platforms. Efforts to improve healthcare coverage, regulatory support, and international collaborations are gradually strengthening the region’s diagnostic capacity and driving market expansion.

Middle East and Africa

The Middle East and Africa region holds the smallest share in the Global NTM Diagnostic Market, with an estimated 5% market share in 2023. The market is characterized by underdiagnosis of NTM infections due to limited access to advanced diagnostics, infrastructural constraints, and workforce shortages. However, ongoing investments in healthcare infrastructure and increasing public awareness are creating opportunities for market growth. Countries in the Gulf Cooperation Council (GCC) and South Africa are leading regional efforts to improve infectious disease management and diagnostic capacity. Partnerships with international organizations and private companies are driving the introduction of automated platforms and point-of-care diagnostics. Over time, sustained investment and capacity-building initiatives are expected to enhance market penetration and support early detection of NTM infections across the Middle East and Africa.

Key Player Analysis

  • Thermo Fisher Scientific Inc
  • Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Bruker Corporation
  • SD Biosensor
  • Bioneer
  • Seegene Inc.

Competitive Analysis

The competitive landscape of the Global NTM Diagnostic Market is characterized by the presence of leading players such as Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company (BD), and bioMérieux SA. These companies maintain a strong foothold through their broad portfolios of molecular and immunological diagnostic solutions, catering to both centralized laboratories and decentralized testing environments. They invest heavily in research and development to introduce advanced assays, automated platforms, and integrated systems that enhance diagnostic speed, accuracy, and workflow efficiency. Strategic partnerships, collaborations with research institutions, and mergers and acquisitions are common approaches to accelerate innovation and expand geographic presence. Key players also focus on regulatory compliance and obtaining international certifications, enabling seamless market entry across regions. Their ability to address evolving clinical needs, support public health initiatives, and offer training and technical support further strengthens their market leadership. The emphasis on affordability, scalability, and digital integration allows these companies to stay competitive while adapting to shifting healthcare demands and regulatory landscapes worldwide.

Recent Developments

  • In January 2022, Spero Therapeutics stated that the FDA had withdrawn the clinical stay imposed on its Phase IIa SPR720 study by the agency. Patients with nontuberculous mycobacterial pulmonary illness are being examined with medication, an oral antibacterial agent (NTM-PD).
  • In January 2022, Gaelan Medical Trade LLC and RedHill Biopharma Ltd., a specialist biopharmaceutical business, have partnered to sell the medication Talicia (omeprazole magnesium, amoxicillin, and rifabutin) in the United Arab Emirates (UAE).
  • In June 2022, for treating pulmonary nontuberculous mycobacterial disorders brought on by Mycobacterium avium complex (MAC) and Mycobacterium abscessus, the FDA granted NUZYRA® from Paratek Pharmaceuticals Fast Track Designation (MAB).

Market Concentration & Characteristics

The Global NTM Diagnostic Market exhibits a moderate to high level of market concentration, with a few multinational corporations accounting for a significant share of total revenue. It features a mix of global leaders and specialized regional players, each contributing to innovation and product development. Leading companies leverage advanced research capabilities, strong distribution networks, and established brand recognition to secure their market positions. The market is characterized by continuous technological advancement, a focus on molecular diagnostics, and a growing shift toward automated and point-of-care testing solutions. It responds to evolving clinical needs by offering assays with improved sensitivity and specificity while navigating regulatory requirements in diverse regions. Product differentiation, customer support services, and integration with digital health platforms distinguish the offerings of top players. The market continues to expand into emerging economies, supported by efforts to address unmet diagnostic needs and promote accessibility to high-quality testing solutions worldwide.

Report Coverage

The research report offers an in-depth analysis based on Diagnostic Method, Infection Type, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Global NTM Diagnostic Market is projected to experience steady growth through 2032, driven by increasing awareness and the need for early detection of non-tuberculous mycobacterial infections.
  2. Advancements in molecular diagnostic technologies, such as PCR and next-generation sequencing, are enhancing the accuracy and speed of NTM detection, facilitating timely treatment decisions.
  3. The integration of automated and point-of-care diagnostic solutions is expanding, improving accessibility in both developed and resource-limited settings.
  4. Key industry players are focusing on strategic collaborations and research investments to develop innovative diagnostic tools and expand their global footprint.
  5. The rising prevalence of chronic respiratory diseases, including COPD and bronchiectasis, is contributing to increased demand for NTM diagnostic services.
  6. Emerging markets in Asia-Pacific and Latin America are witnessing growth opportunities due to healthcare infrastructure development and increased investment in diagnostic capabilities.
  7. Regulatory support and government initiatives aimed at controlling infectious diseases are encouraging the adoption of advanced diagnostic methods.
  8. Challenges such as high costs of advanced diagnostics and limited access in certain regions may hinder market growth, necessitating affordable and scalable solutions.
  9. The market is expected to benefit from the growing trend of personalized medicine, with diagnostics playing a crucial role in tailoring treatments for NTM infections.
  10. Continuous innovation and technological advancements are anticipated to shape the future landscape of the Global NTM Diagnostic Market, enhancing diagnostic accuracy and patient outcomes.

Table of Content
CHAPTER NO. 1 : INTRODUCTION………………………………………………………………….. 35
1.1.1. Report Description ………………………………………………………………………………………….. 35
Purpose of the Report………………………………………………………………………………………. 35
USP & Key Offerings…………………………………………………………………………………………. 35
1.1.2. Key Benefits for Stakeholders……………………………………………………………………………. 35
1.1.3. Target Audience ……………………………………………………………………………………………… 36
1.1.4. Report Scope 36
1.1.5. Regional Scope ……………………………………………………………………………………………….. 37
CHAPTER NO. 2 : EXECUTIVE SUMMARY ………………………………………………………… 38
2.1. NTM Diagnostic Market Snapshot……………………………………………………………………… 38
2.1.1. Global NTM Diagnostic Market, 2018 – 2032 (USD Million) ……………………………………. 41
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS ……………………………….. 42
3.1. Russia-Ukraine and Israel-Palestine War Impacts…………………………………………………. 42
CHAPTER NO. 4 : NTM DIAGNOSTIC MARKET – INDUSTRY ANALYSIS …………………. 43
4.1. Introduction 43
4.2. Market Drivers………………………………………………………………………………………………… 44
4.2.1. Increasing Prevalence of NTM Infections…………………………………………………………….. 44
4.2.2. Advancements in Diagnostic Technology…………………………………………………………….. 44
4.2.3. Growing Research and Development & Expanding Healthcare Infrastructure…………… 45
4.3. Market Restraints……………………………………………………………………………………………. 46
4.3.1. High Costs of Advanced Diagnostics and Complexity in Diagnosis…………………………… 46
4.3.2. Limited Awareness and Training and Regulatory and Reimbursement Challenges…….. 47
4.4. Market Opportunities………………………………………………………………………………………. 48
4.4.1. Emerging Markets …………………………………………………………………………………………… 48
4.5. Porter’s Five Forces Analysis……………………………………………………………………………… 49
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE…………………………………….. 50
5.1. Company Market Share Analysis – 2023……………………………………………………………… 50
5.1.1. Global NTM Diagnostic Market: Company Market Share, by Revenue, 2023 ……………. 50
5.2. Global NTM Diagnostic Market Company Revenue Market Share, 2023 ………………….. 51
5.3. Company Assessment Metrics, 2023 ………………………………………………………………….. 52
5.4. Key Players Product Matrix ………………………………………………………………………………. 53
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS………………………………… 55
6.1. PESTEL 55
CHAPTER NO. 7 : NTM DIAGNOSTIC MARKET – BY DIAGNOSTIC METHOD SEGMENT
ANALYSIS ………………………………………………………………………….. 57
7.1. NTM Diagnostic Market Overview, by Diagnostic Method Segment……………………….. 57
7.1.1. NTM Diagnostic Market Revenue Share, By Diagnostic Method, 2023 & 2032………….. 57
7.1.2. NTM Diagnostic Market Attractiveness Analysis, By Diagnostic Method …………………. 59
7.1.3. Incremental Revenue Growth Opportunity, by Diagnostic Method, 2024 – 2032 ………. 60
7.1.4. NTM Diagnostic Market Revenue, By Diagnostic Method, 2018, 2023, 2027 & 2032 …. 61
7.2. Nucleic Acid Amplification Tests (NAAT)……………………………………………………………… 62
7.3. Microscopy 63
7.4. Culture-based Methods……………………………………………………………………………………. 64
7.5. Biochemical Tests……………………………………………………………………………………………. 65
7.6. Immunological Tests………………………………………………………………………………………… 66
7.7. PCR 67
7.8. Others 68
CHAPTER NO. 8 : NTM DIAGNOSTIC MARKET – BY NTM INFECTION TYPE SEGMENT
ANALYSIS ………………………………………………………………………….. 69
8.1. NTM Diagnostic Market Overview, by NTM Infection Type Segment………………………. 69
8.1.1. NTM Diagnostic Market Revenue Share, By NTM Infection Type, 2023 & 2032 ………… 69
8.1.2. NTM Diagnostic Market Attractiveness Analysis, By NTM Infection Type ………………… 71
8.1.3. Incremental Revenue Growth Opportunity, by NTM Infection Type, 2024 – 2032 ……… 72
8.1.4. NTM Diagnostic Market Revenue, By NTM Infection Type, 2018, 2023, 2027 & 2032 … 73
8.2. Pulmonary 74
8.3. Cutaneous 75
8.4. Disseminated 76
8.5. Gastrointestinal………………………………………………………………………………………………. 77
8.6. Others 78
CHAPTER NO. 9 : NTM DIAGNOSTIC MARKET – BY END-USER SEGMENT ANALYSIS 79
9.1. NTM Diagnostic Market Overview, by End-user Segment ……………………………………… 79
9.1.1. NTM Diagnostic Market Revenue Share, By End-user, 2023 & 2032………………………… 79
9.1.2. NTM Diagnostic Market Attractiveness Analysis, By End-user………………………………… 81
9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 …………………….. 82
9.1.4. NTM Diagnostic Market Revenue, By End-user, 2018, 2023, 2027 & 2032 ……………….. 83
9.2. Hospitals & Clinics …………………………………………………………………………………………… 84
9.3. Diagnostic Laboratories……………………………………………………………………………………. 85
9.4. Others 86
CHAPTER NO. 10 : NTM DIAGNOSTIC MARKET – REGIONAL ANALYSIS…………………. 87
10.1. NTM Diagnostic Market Overview, by Regional Segments…………………………………….. 87
10.2. Region 87
10.2.1.Global NTM Diagnostic Market Revenue Share, By Region, 2023 & 2032…………………. 87
10.2.2.NTM Diagnostic Market Attractiveness Analysis, By Region…………………………………… 89
10.2.3.Incremental Revenue Growth Opportunity, by Region, 2024 – 2032 ……………………….. 90
10.2.4.NTM Diagnostic Market Revenue, By Region, 2018, 2023, 2027 & 2032…………………… 91
10.2.5.Global NTM Diagnostic Market Revenue, By Region, 2018 – 2023 (USD Million)……….. 92
10.2.6.Global NTM Diagnostic Market Revenue, By Region, 2024 – 2032 (USD Million)……….. 92
10.3. Diagnostic Method ………………………………………………………………………………………….. 93
10.3.1.Global NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 93
10.3.2.Global NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) 93
10.4. NTM Infection Type…………………………………………………………………………………………. 94
10.4.1.Global NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 94
10.4.2.Global NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) 94
10.5. End-user 95
10.5.1.Global NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…….. 95
10.5.2.Global NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…….. 95
CHAPTER NO. 11 : NTM DIAGNOSTIC MARKET – NORTH AMERICA ……………………… 96
11.1. North America96
11.1.1.Key Highlights 97
11.1.2.North America NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million)
98
11.1.3.North America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million) 99
11.1.4.North America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million) 100
11.1.5.North America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)
101
11.2. U.S. 102
11.2.1.U.S. NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
102
11.2.2.U.S. NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
103
11.2.3.U.S. NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………. 104
11.3. Canada 105
11.3.1.Canada NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 105
11.3.2.Canada NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 106
11.3.3.Canada NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)….. 107
11.4. Mexico 108
11.4.1.Mexico NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 108
11.4.2.Mexico NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 109
11.4.3.Mexico NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)….. 110
CHAPTER NO. 12 : NTM DIAGNOSTIC MARKET – EUROPE…………………………………. 111
12.1. Europe 111
12.1.1.Key Highlights 112
12.1.2.Europe NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) …… 113
12.1.3.Europe NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 114
12.1.4.Europe NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 115
12.1.5.Europe NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)….. 116
12.2. UK 117
12.2.1.UK NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
117
12.2.2.UK NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
118
12.2.3.UK NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………… 119
12.3. France 120
12.3.1.France NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 120
12.3.2.France NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 121
12.3.3.France NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…… 122
12.4. Germany 123
12.4.1.Germany NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 123
12.4.2.Germany NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 124
12.4.3.Germany NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million).. 125
12.5. Italy 126
12.5.1.Italy NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
126
12.5.2.Italy NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
127
12.5.3.Italy NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……… 128
12.6. Spain 129
12.6.1.Spain NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 129
12.6.2.Spain NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 130
12.6.3.Spain NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…….. 131
12.7. Russia 132
12.7.1.Russia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 132
12.7.2.Russia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 133
12.7.3.Russia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …… 134
12.8. Belgium 135
12.8.1.Belgium NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 135
12.8.2.Belgium NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 136
12.8.3.Belgium NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) … 137
12.9. Netherland 138
12.9.1.Netherland NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 138
12.9.2.Netherland NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 139
12.9.3.Netherland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)140
12.10. Austria 141
12.10.1. Austria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 141
12.10.2. Austria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 142
12.10.3. Austria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 143
12.11. Sweden 144
12.11.1. Sweden NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 144
12.11.2. Sweden NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 145
12.11.3. Sweden NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 146
12.12. Poland 147
12.12.1. Poland NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 147
12.12.2. Poland NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 148
12.12.3. Poland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 149
12.13. Denmark 150
12.13.1. Denmark NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 150
12.13.2. Denmark NTM Diagnostic Market Revenue, By NTM Infection Type, 2018
– 2023 (USD Million)……………………………………………………………………………………….. 151
12.13.3. Denmark NTM Diagnostic Market Revenue, By End-user, 2018 – 2023
(USD Million) 152
12.14. Switzerland 153
12.14.1. Switzerland NTM Diagnostic Market Revenue, By Diagnostic Method,
2018 – 2023 (USD Million)……………………………………………………………………………….. 153
12.14.2. Switzerland NTM Diagnostic Market Revenue, By NTM Infection Type,
2018 – 2023 (USD Million)……………………………………………………………………………….. 154
12.14.3. Switzerland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023
(USD Million) 155
12.15. Rest of Europe156
12.15.1. Rest of Europe NTM Diagnostic Market Revenue, By Diagnostic Method,
2018 – 2023 (USD Million)……………………………………………………………………………….. 156
12.15.2. Rest of Europe NTM Diagnostic Market Revenue, By NTM Infection Type,
2018 – 2023 (USD Million)……………………………………………………………………………….. 157
12.15.3. Rest of Europe NTM Diagnostic Market Revenue, By End-user, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 158
CHAPTER NO. 13 : NTM DIAGNOSTIC MARKET – ASIA PACIFIC ………………………….. 159
13.1. Asia Pacific 159
13.1.1.Key Highlights 160
13.1.2.Asia Pacific NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) 162
13.1.3.Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 163
13.1.4.Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 164
13.1.5.Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)165
13.2. China 166
13.2.1.China NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 166
13.2.2.China NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 167
13.2.3.China NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……. 168
13.3. Japan 169
13.3.1.Japan NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 169
13.3.2.Japan NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 170
13.3.3.Japan NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……. 171
13.4. South Korea 172
13.4.1.South Korea NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 172
13.4.2.South Korea NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 173
13.4.3.South Korea NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)
174
13.5. India 175
13.5.1.India NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
175
13.5.2.India NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 176
13.5.3.India NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …….. 177
13.6. Australia 178
13.6.1.Australia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 178
13.6.2.Australia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 179
13.6.3.Australia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million).. 180
13.7. Thailand 181
13.7.1.Thailand NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 181
13.7.2.Thailand NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 182
13.7.3.Thailand NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)… 183
13.8. Indonesia 184
13.8.1.Indonesia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 184
13.8.2.Indonesia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 185
13.8.3.Indonesia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million). 186
13.9. Vietnam 187
13.9.1.Vietnam NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 187
13.9.2.Vietnam NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 188
13.9.3.Vietnam NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)… 189
13.10. Malaysia 190
13.10.1. Malaysia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 190
13.10.2. Malaysia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 191
13.10.3. Malaysia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 192
13.11. Philippines 193
13.11.1. Philippines NTM Diagnostic Market Revenue, By Diagnostic Method, 2018
– 2023 (USD Million)……………………………………………………………………………………….. 193
13.11.2. Philippines NTM Diagnostic Market Revenue, By NTM Infection Type,
2018 – 2023 (USD Million)……………………………………………………………………………….. 194
13.11.3. Philippines NTM Diagnostic Market Revenue, By End-user, 2018 – 2023
(USD Million) 195
13.12. Taiwan 196
13.12.1. Taiwan NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 196
13.12.2. Taiwan NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 197
13.12.3. Taiwan NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 198
13.13. Rest of Asia Pacific…………………………………………………………………………………………. 199
13.13.1. Rest of Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic
Method, 2018 – 2023 (USD Million) ………………………………………………………………….. 199
13.13.2. Rest of Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection
Type, 2018 – 2023 (USD Million) ………………………………………………………………………. 200
13.13.3. Rest of Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 201
CHAPTER NO. 14 : NTM DIAGNOSTIC MARKET – LATIN AMERICA ……………………… 202
14.1. Latin America 202
14.1.1.Key Highlights 203
14.1.2.Latin America NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million)
204
14.1.3.Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million) 205
14.1.4.Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million) 206
14.1.5.Latin America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)
207
14.2. Brazil 208
14.2.1.Brazil NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 208
14.2.2.Brazil NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 209
14.2.3.Brazil NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……. 210
14.3. Argentina 211
14.3.1.Argentina NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 211
14.3.2.Argentina NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 212
14.3.3.Argentina NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million). 213
14.4. Peru 214
14.4.1.Peru NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
214
14.4.2.Peru NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 215
14.4.3.Peru NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……… 216
14.5. Chile 217
14.5.1.Chile NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
217
14.5.2.Chile NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 218
14.5.3.Chile NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …….. 219
14.6. Colombia 220
14.6.1.Colombia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 220
14.6.2.Colombia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 221
14.6.3.Colombia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) . 222
14.7. Rest of Latin America……………………………………………………………………………………… 223
14.7.1.Rest of Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 223
14.7.2.Rest of Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 224
14.7.3.Rest of Latin America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 225
CHAPTER NO. 15 : NTM DIAGNOSTIC MARKET – MIDDLE EAST …………………………. 226
15.1. Middle East 226
15.1.1.Key Highlights 227
15.1.2.Middle East NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million)229
15.1.3.Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 230
15.1.4.Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 231
15.1.5.Middle East NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)232
15.2. UAE 233
15.2.1.UAE NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
233
15.2.2.UAE NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
234
15.2.3.UAE NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………. 235
15.3. KSA 236
15.3.1.KSA NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
236
15.3.2.KSA NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
237
15.3.3.KSA NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………. 238
15.4. Israel 239
15.4.1.Israel NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 239
15.4.2.Israel NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 240
15.4.3.Israel NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…….. 241
15.5. Turkey 242
15.5.1.Turkey NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 242
15.5.2.Turkey NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 243
15.5.3.Turkey NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ….. 244
15.6. Iran 245
15.6.1.Iran NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)
245
15.6.2.Iran NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)
246
15.6.3.Iran NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………. 247
15.7. Rest of Middle East………………………………………………………………………………………… 248
15.7.1.Rest of Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 248
15.7.2.Rest of Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)…………………………………………………………………………………………. 249
15.7.3.Rest of Middle East NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) 250
CHAPTER NO. 16 : NTM DIAGNOSTIC MARKET – AFRICA ………………………………….. 251
16.1. Africa 251
16.1.1.Key Highlights 252
16.1.2.Africa NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) …….. 253
16.1.3.Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 254
16.1.4.Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 255
16.1.5.Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……. 256
16.2. South Africa 257
16.2.1.South Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 257
16.2.2.South Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 258
16.2.3.South Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)
259
16.3. Egypt 260
16.3.1.Egypt NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 260
16.3.2.Egypt NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 261
16.3.3.Egypt NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……. 262
16.4. Algeria 263
16.4.1.Algeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 263
16.4.2.Algeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 264
16.4.3.Algeria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ….. 265
16.5. Nigeria 266
16.5.1.Nigeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 266
16.5.2.Nigeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 267
16.5.3.Nigeria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)….. 268
16.6. Morocco 269
16.6.1.Morocco NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 269
16.6.2.Morocco NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) 270
16.6.3.Morocco NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) .. 271
16.7. Rest of Africa 272
16.7.1.Rest of Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) 272
16.7.2.Rest of Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million) 273
16.7.3.Rest of Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)
274
CHAPTER NO. 17 : COMPANY PROFILES …………………………………………………………. 275
17.1. Thermo Fisher Scientific Inc…………………………………………………………………………….. 275
17.1.1.Company Overview ……………………………………………………………………………………….. 275
17.1.2.Products Portfolio………………………………………………………………………………………….. 276
17.1.3.Financial Overview ………………………………………………………………………………………… 276
17.2. F. Hoffmann-La Roche Ltd……………………………………………………………………………….. 277
17.2.1.Company Overview ……………………………………………………………………………………….. 277
17.2.2.Product Portfolio …………………………………………………………………………………………… 277
17.2.3.Financial Overview ………………………………………………………………………………………… 278
17.3. Becton, Dickinson and Company (BD)……………………………………………………………….. 279
17.3.1.Company Overview ……………………………………………………………………………………….. 279
17.3.2.Product Portfolio …………………………………………………………………………………………… 280
17.3.3.Financial Overview ………………………………………………………………………………………… 280
17.4. bioMérieux SA281
17.4.1.Company Overview ……………………………………………………………………………………….. 281
17.4.2.Product Portfolio …………………………………………………………………………………………… 282
17.4.3.Financial Overview ………………………………………………………………………………………… 282
17.5. Bruker Corporation………………………………………………………………………………………… 283
17.5.1.Company Overview ……………………………………………………………………………………….. 283
17.5.2.Product Portfolio …………………………………………………………………………………………… 284
17.5.3.Financial Overview ………………………………………………………………………………………… 284
17.6. SD Biosensor 285
17.6.1.Company Overview ……………………………………………………………………………………….. 285
17.6.2.Product Portfolio …………………………………………………………………………………………… 285
17.6.3.Financial Overview ………………………………………………………………………………………… 286
17.7. Bioneer 287
17.7.1.Company Overview ……………………………………………………………………………………….. 287
17.7.2.Product Portfolio …………………………………………………………………………………………… 287
17.7.3.Financial Overview ………………………………………………………………………………………… 288
17.8. Seegene Inc. 289
17.8.1.Company Overview ……………………………………………………………………………………….. 289
17.8.2.Product Portfolio …………………………………………………………………………………………… 289
17.8.3.Financial Overview ………………………………………………………………………………………… 290
CHAPTER NO. 18 : NTM AND TB CO-TESTING OVERVIEW …………………………………. 291
18.1. NTM and TB co-testing overview……………………………………………………………………… 291
18.2. % of NTM and TB co-testing overview………………………………………………………………. 293
CHAPTER NO. 19 : PRICE ANALYSIS ……………………………………………………………….. 295
19.1. Price Range of Molecular PCR Assays for NTM …………………………………………………… 295
19.2. Microscopy 295
19.3. Culture-based Methods………………………………………………………………………………….. 296
19.4. Biochemical Tests………………………………………………………………………………………….. 296
19.5. Immunological Tests………………………………………………………………………………………. 296
CHAPTER NO. 20 : RESEARCH METHODOLOGY ……………………………………………….. 297
20.1. Research Methodology…………………………………………………………………………………… 297
20.1.1.Phase I – Secondary Research ………………………………………………………………………….. 298
20.1.2.Phase II – Data Modeling…………………………………………………………………………………. 298
Company Share Analysis Model………………………………………………………………………… 299
Revenue Based Modeling ………………………………………………………………………………… 299
20.1.3.Phase III – Primary Research ……………………………………………………………………………. 300
20.1.4.Research Limitations ……………………………………………………………………………………… 301
Assumptions …………………………………………………………………………………………………. 301

List of Figures
FIG NO. 1. Global NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million) …………………………….. 41
FIG NO. 2. Porter’s Five Forces Analysis for Global NTM Diagnostic Market ………………………………….. 49
FIG NO. 3. Company Share Analysis, 2023 ………………………………………………………………………………. 50
FIG NO. 4. NTM Diagnostic Market – Company Revenue Market Share, 2023……………………………….. 51
FIG NO. 5. Company Assessment Matrix ………………………………………………………………………………… 52
FIG NO. 6. NTM Diagnostic Market Revenue Share, By Diagnostic Method, 2023 & 2032………………… 57
FIG NO. 7. Market Attractiveness Analysis, By Diagnostic Method………………………………………………. 59
FIG NO. 8. Incremental Revenue Growth Opportunity by Diagnostic Method, 2024 – 2032 ……………… 60
FIG NO. 9. NTM Diagnostic Market Revenue, By Diagnostic Method, 2018, 2023, 2027 & 2032 ……….. 61
FIG NO. 10. Global NTM Diagnostic Market for Nucleic Acid Amplification Tests (NAAT), Revenue (USD
Million) 2018 – 2032…………………………………………………………………………………………….. 62
FIG NO. 11. Global NTM Diagnostic Market for Microscopy, Revenue (USD Million) 2018 – 2032 ……….. 63
FIG NO. 12. Global NTM Diagnostic Market for Culture-based Methods, Revenue (USD Million) 2018 –
2032 …………………………………………………………………………………………………………………. 64
FIG NO. 13. Global NTM Diagnostic Market for Biochemical Tests, Revenue (USD Million) 2018 – 2032.. 65
FIG NO. 14. Global NTM Diagnostic Market for Immunological Tests, Revenue (USD Million) 2018 –
2032 …………………………………………………………………………………………………………………. 66
FIG NO. 15. Global NTM Diagnostic Market for PCR, Revenue (USD Million) 2018 – 2032………………….. 67
FIG NO. 16. Global NTM Diagnostic Market for Others, Revenue (USD Million) 2018 – 2032………………. 68
FIG NO. 17. NTM Diagnostic Market Revenue Share, By NTM Infection Type, 2023 & 2032 ………………. 69
FIG NO. 18. Market Attractiveness Analysis, By NTM Infection Type……………………………………………… 71
FIG NO. 19. Incremental Revenue Growth Opportunity by NTM Infection Type, 2024 – 2032…………….. 72
FIG NO. 20. NTM Diagnostic Market Revenue, By NTM Infection Type, 2018, 2023, 2027 & 2032 ………. 73
FIG NO. 21. Global NTM Diagnostic Market for Pulmonary, Revenue (USD Million) 2018 – 2032 ………… 74
FIG NO. 22. Global NTM Diagnostic Market for Cutaneous, Revenue (USD Million) 2018 – 2032…………. 75
FIG NO. 23. Global NTM Diagnostic Market for Disseminated, Revenue (USD Million) 2018 – 2032 …….. 76
FIG NO. 24. Global NTM Diagnostic Market for Gastrointestinal, Revenue (USD Million) 2018 – 2032 …. 77
FIG NO. 25. Global NTM Diagnostic Market for Others, Revenue (USD Million) 2018 – 2032………………. 78
FIG NO. 26. NTM Diagnostic Market Revenue Share, By End-user, 2023 & 2032……………………………… 79
FIG NO. 27. Market Attractiveness Analysis, By End-user…………………………………………………………….. 81
FIG NO. 28. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032……………………………. 82
FIG NO. 29. NTM Diagnostic Market Revenue, By End-user, 2018, 2023, 2027 & 2032……………………… 83
FIG NO. 30. Global NTM Diagnostic Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032. 84
FIG NO. 31. Global NTM Diagnostic Market for Diagnostic Laboratories, Revenue (USD Million) 2018 –
2032 …………………………………………………………………………………………………………………. 85
FIG NO. 32. Global NTM Diagnostic Market for Others, Revenue (USD Million) 2018 – 2032………………. 86
FIG NO. 33. Global NTM Diagnostic Market Revenue Share, By Region, 2023 & 2032 ………………………. 87
FIG NO. 34. Market Attractiveness Analysis, By Region……………………………………………………………….. 89
FIG NO. 35. Incremental Revenue Growth Opportunity by Region, 2024 – 2032………………………………. 90
FIG NO. 36. NTM Diagnostic Market Revenue, By Region, 2018, 2023, 2027 & 2032………………………… 91
FIG NO. 37. North America NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million)…………………. 96
FIG NO. 38. Europe NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million) …………………………..111
FIG NO. 39. Asia Pacific NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million) ……………………..159
FIG NO. 40. Latin America NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million) ………………….202
FIG NO. 41. Middle East NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million) …………………….226
FIG NO. 42. Africa NTM Diagnostic Market Revenue, 2018 – 2032 (USD Million)……………………………..251
FIG NO. 43. Research Methodology – Detailed View ………………………………………………………………….297
FIG NO. 44. Research Methodology ………………………………………………………………………………………..298

List of Tables
TABLE NO. 1. : Global NTM Diagnostic Market: Snapshot………………………………………………………………… 38
TABLE NO. 2. : Drivers for the NTM Diagnostic Market: Impact Analysis…………………………………………….. 44
TABLE NO. 3. : Restraints for the NTM Diagnostic Market: Impact Analysis………………………………………… 46
TABLE NO. 4. : Global NTM Diagnostic Market Revenue, By Region, 2018 – 2023 (USD Million) ……………… 92
TABLE NO. 5. : Global NTM Diagnostic Market Revenue, By Region, 2024 – 2032 (USD Million) ……………… 92
TABLE NO. 6. : Global NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………… 93
TABLE NO. 7. : Global NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………… 93
TABLE NO. 8. : Global NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………… 94
TABLE NO. 9. : Global NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………… 94
TABLE NO. 10. : Global NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………… 95
TABLE NO. 11. : Global NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………… 95
TABLE NO. 12. : North America NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million)…. 98
TABLE NO. 13. : North America NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million)…. 98
TABLE NO. 14. : North America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million)………………………………………………………………………………………………………. 99
TABLE NO. 15. : North America NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032
(USD Million)………………………………………………………………………………………………………. 99
TABLE NO. 16. : North America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million)………………………………………………………………………………………………………100
TABLE NO. 17. : North America NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032
(USD Million)………………………………………………………………………………………………………100
TABLE NO. 18. : North America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) .101
TABLE NO. 19. : North America NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) .101
TABLE NO. 20. : U.S. NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million) ..102
TABLE NO. 21. : U.S. NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million) ..102
TABLE NO. 22. : U.S. NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million) .103
TABLE NO. 23. : U.S. NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million) .103
TABLE NO. 24. : U.S. NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………………104
TABLE NO. 25. : U.S. NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………………104
TABLE NO. 26. : Canada NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..105
TABLE NO. 27. : Canada NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..105
TABLE NO. 28. : Canada NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..106
TABLE NO. 29. : Canada NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..106
TABLE NO. 30. : Canada NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….107
24 | P a g e
GLOBAL NTM DIAGNOSTIC MARKET, 2018 – 2032
TABLE NO. 31. : Canada NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….107
TABLE NO. 32. : Mexico NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..108
TABLE NO. 33. : Mexico NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..108
TABLE NO. 34. : Mexico NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..109
TABLE NO. 35. : Mexico NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..109
TABLE NO. 36. : Mexico NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….110
TABLE NO. 37. : Mexico NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….110
TABLE NO. 38. : Europe NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) …………..113
TABLE NO. 39. : Europe NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million) …………..113
TABLE NO. 40. : Europe NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..114
TABLE NO. 41. : Europe NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..114
TABLE NO. 42. : Europe NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..115
TABLE NO. 43. : Europe NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..115
TABLE NO. 44. : Europe NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….116
TABLE NO. 45. : Europe NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….116
TABLE NO. 46. : UK NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)….117
TABLE NO. 47. : UK NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)….117
TABLE NO. 48. : UK NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)…118
TABLE NO. 49. : UK NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million)…118
TABLE NO. 50. : UK NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………………..119
TABLE NO. 51. : UK NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………………..119
TABLE NO. 52. : France NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..120
TABLE NO. 53. : France NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..120
TABLE NO. 54. : France NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..121
TABLE NO. 55. : France NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..121
TABLE NO. 56. : France NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………..122
TABLE NO. 57. : France NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………..122
TABLE NO. 58. : Germany NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..123
TABLE NO. 59. : Germany NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..123
TABLE NO. 60. : Germany NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..124
TABLE NO. 61. : Germany NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..124
TABLE NO. 62. : Germany NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……….125
TABLE NO. 63. : Germany NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……….125
TABLE NO. 64. : Italy NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)..126
TABLE NO. 65. : Italy NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)..126
TABLE NO. 66. : Italy NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million).127
TABLE NO. 67. : Italy NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million).127
TABLE NO. 68. : Italy NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……………..128
TABLE NO. 69. : Italy NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……………..128
TABLE NO. 70. : Spain NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million) 129
TABLE NO. 71. : Spain NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million) 129
TABLE NO. 72. : Spain NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..130
TABLE NO. 73. : Spain NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..130
TABLE NO. 74. : Spain NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………….131
TABLE NO. 75. : Spain NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………….131
TABLE NO. 76. : Russia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..132
TABLE NO. 77. : Russia NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..132
TABLE NO. 78. : Russia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..133
TABLE NO. 79. : Russia NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..133
TABLE NO. 80. : Russia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …………..134
TABLE NO. 81. : Russia NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …………..134
TABLE NO. 82. : Belgium NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..135
TABLE NO. 83. : Belgium NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..135
TABLE NO. 84. : Belgium NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..136
TABLE NO. 85. : Belgium NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million)……………………………………………………………………………………………………………..136
TABLE NO. 86. : Belgium NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………137
TABLE NO. 87. : Belgium NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………137
TABLE NO. 88. : Netherland NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..138
TABLE NO. 89. : Netherland NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..138
TABLE NO. 90. : Netherland NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..139
TABLE NO. 91. : Netherland NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..139
TABLE NO. 92. : Netherland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…….140
TABLE NO. 93. : Netherland NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…….140
TABLE NO. 94. : Austria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..141
TABLE NO. 95. : Austria NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..141
TABLE NO. 96. : Austria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..142
TABLE NO. 97. : Austria NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..142
TABLE NO. 98. : Austria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….143
TABLE NO. 99. : Austria NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….143
TABLE NO. 100. : Sweden NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million)……………………………………………………………………………………………………………..144
TABLE NO. 101. : Sweden NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..144
TABLE NO. 102. : Sweden NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..145
TABLE NO. 103. : Sweden NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..145
TABLE NO. 104. : Sweden NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………146
TABLE NO. 105. : Sweden NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………146
TABLE NO. 106. : Poland NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..147
TABLE NO. 107. : Poland NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..147
TABLE NO. 108. : Poland NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..148
TABLE NO. 109. : Poland NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..148
TABLE NO. 110. : Poland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ………….149
TABLE NO. 111. : Poland NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ………….149
TABLE NO. 112. : Denmark NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..150
TABLE NO. 113. : Denmark NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..150
TABLE NO. 114. : Denmark NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..151
TABLE NO. 115. : Denmark NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..151
TABLE NO. 116. : Denmark NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……….152
TABLE NO. 117. : Denmark NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……….152
TABLE NO. 118. : Switzerland NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..153
TABLE NO. 119. : Switzerland NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..153
TABLE NO. 120. : Switzerland NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..154
TABLE NO. 121. : Switzerland NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..154
TABLE NO. 122. : Switzerland NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……155
TABLE NO. 123. : Switzerland NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……155
TABLE NO. 124. : Rest of Europe NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million)………………………………………………………………………………………………………156
TABLE NO. 125. : Rest of Europe NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032
(USD Million)………………………………………………………………………………………………………156
TABLE NO. 126. : Rest of Europe NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million)………………………………………………………………………………………………………157
TABLE NO. 127. : Rest of Europe NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032
(USD Million)………………………………………………………………………………………………………157
TABLE NO. 128. : Rest of Europe NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) .158
TABLE NO. 129. : Rest of Europe NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) .158
TABLE NO. 130. : Asia Pacific NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) ……..162
TABLE NO. 131. : Asia Pacific NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million) ……..162
TABLE NO. 132. : Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..163
TABLE NO. 133. : Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..163
TABLE NO. 134. : Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..164
TABLE NO. 135. : Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..164
TABLE NO. 136. : Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…….165
TABLE NO. 137. : Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…….165
TABLE NO. 138. : China NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)166
TABLE NO. 139. : China NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)166
TABLE NO. 140. : China NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..167
TABLE NO. 141. : China NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..167
TABLE NO. 142. : China NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……………168
TABLE NO. 143. : China NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……………168
TABLE NO. 144. : Japan NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)169
TABLE NO. 145. : Japan NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)169
TABLE NO. 146. : Japan NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..170
TABLE NO. 147. : Japan NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..170
TABLE NO. 148. : Japan NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……………171
TABLE NO. 149. : Japan NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……………171
TABLE NO. 150. : South Korea NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..172
TABLE NO. 151. : South Korea NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..172
TABLE NO. 152. : South Korea NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..173
TABLE NO. 153. : South Korea NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..173
TABLE NO. 154. : South Korea NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …..174
TABLE NO. 155. : South Korea NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …..174
TABLE NO. 156. : India NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million).175
TABLE NO. 157. : India NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million).175
TABLE NO. 158. : India NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)176
TABLE NO. 159. : India NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million)176
TABLE NO. 160. : India NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …………….177
TABLE NO. 161. : India NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …………….177
TABLE NO. 162. : Australia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..178
TABLE NO. 163. : Australia NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..178
TABLE NO. 164. : Australia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..179
TABLE NO. 165. : Australia NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..179
TABLE NO. 166. : Australia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……….180
TABLE NO. 167. : Australia NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……….180
TABLE NO. 168. : Thailand NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..181
TABLE NO. 169. : Thailand NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..181
TABLE NO. 170. : Thailand NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..182
TABLE NO. 171. : Thailand NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..182
TABLE NO. 172. : Thailand NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………..183
TABLE NO. 173. : Thailand NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………..183
TABLE NO. 174. : Indonesia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..184
TABLE NO. 175. : Indonesia NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..184
TABLE NO. 176. : Indonesia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..185
TABLE NO. 177. : Indonesia NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..185
TABLE NO. 178. : Indonesia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………186
TABLE NO. 179. : Indonesia NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………186
TABLE NO. 180. : Vietnam NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..187
TABLE NO. 181. : Vietnam NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..187
TABLE NO. 182. : Vietnam NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..188
TABLE NO. 183. : Vietnam NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..188
TABLE NO. 184. : Vietnam NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………..189
TABLE NO. 185. : Vietnam NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………..189
TABLE NO. 186. : Malaysia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..190
TABLE NO. 187. : Malaysia NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..190
TABLE NO. 188. : Malaysia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..191
TABLE NO. 189. : Malaysia NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..191
TABLE NO. 190. : Malaysia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……….192
TABLE NO. 191. : Malaysia NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……….192
TABLE NO. 192. : Philippines NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..193
TABLE NO. 193. : Philippines NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..193
TABLE NO. 194. : Philippines NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..194
TABLE NO. 195. : Philippines NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..194
TABLE NO. 196. : Philippines NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …….195
TABLE NO. 197. : Philippines NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …….195
TABLE NO. 198. : Taiwan NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..196
TABLE NO. 199. : Taiwan NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..196
TABLE NO. 200. : Taiwan NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..197
TABLE NO. 201. : Taiwan NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..197
TABLE NO. 202. : Taiwan NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….198
TABLE NO. 203. : Taiwan NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….198
TABLE NO. 204. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million)………………………………………………………………………………………………………199
TABLE NO. 205. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032
(USD Million)………………………………………………………………………………………………………199
TABLE NO. 206. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million)………………………………………………………………………………………………………200
TABLE NO. 207. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032
(USD Million)………………………………………………………………………………………………………200
TABLE NO. 208. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..201
TABLE NO. 209. : Rest of Asia Pacific NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..201
TABLE NO. 210. : Latin America NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) ….204
TABLE NO. 211. : Latin America NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million) ….204
TABLE NO. 212. : Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..205
TABLE NO. 213. : Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..205
TABLE NO. 214. : Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023
(USD Million)………………………………………………………………………………………………………206
TABLE NO. 215. : Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032
(USD Million)………………………………………………………………………………………………………206
TABLE NO. 216. : Latin America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…207
TABLE NO. 217. : Latin America NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…207
TABLE NO. 218. : Brazil NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)208
TABLE NO. 219. : Brazil NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)208
TABLE NO. 220. : Brazil NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..209
TABLE NO. 221. : Brazil NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..209
TABLE NO. 222. : Brazil NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………….210
TABLE NO. 223. : Brazil NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………….210
TABLE NO. 224. : Argentina NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..211
TABLE NO. 225. : Argentina NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..211
TABLE NO. 226. : Argentina NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..212
TABLE NO. 227. : Argentina NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..212
TABLE NO. 228. : Argentina NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………213
TABLE NO. 229. : Argentina NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………213
TABLE NO. 230. : Peru NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million) .214
TABLE NO. 231. : Peru NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million) .214
TABLE NO. 232. : Peru NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million) 215
TABLE NO. 233. : Peru NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million) 215
TABLE NO. 234. : Peru NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……………..216
TABLE NO. 235. : Peru NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……………..216
TABLE NO. 236. : Chile NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million).217
TABLE NO. 237. : Chile NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million).217
TABLE NO. 238. : Chile NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)218
TABLE NO. 239. : Chile NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million)218
TABLE NO. 240. : Chile NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …………….219
TABLE NO. 241. : Chile NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …………….219
TABLE NO. 242. : Colombia NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..220
TABLE NO. 243. : Colombia NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..220
TABLE NO. 244. : Colombia NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..221
TABLE NO. 245. : Colombia NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..221
TABLE NO. 246. : Colombia NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ………222
TABLE NO. 247. : Colombia NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ………222
TABLE NO. 248. : Rest of Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 –
2023 (USD Million)………………………………………………………………………………………………223
TABLE NO. 249. : Rest of Latin America NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 –
2032 (USD Million)………………………………………………………………………………………………223
TABLE NO. 250. : Rest of Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)………………………………………………………………………………………………224
TABLE NO. 251. : Rest of Latin America NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 –
2032 (USD Million)………………………………………………………………………………………………224
TABLE NO. 252. : Rest of Latin America NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..225
TABLE NO. 253. : Rest of Latin America NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..225
TABLE NO. 254. : Middle East NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) …….229
TABLE NO. 255. : Middle East NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million) …….229
TABLE NO. 256. : Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..230
TABLE NO. 257. : Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..230
TABLE NO. 258. : Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..231
TABLE NO. 259. : Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..231
TABLE NO. 260. : Middle East NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……232
TABLE NO. 261. : Middle East NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……232
TABLE NO. 262. : UAE NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)..233
TABLE NO. 263. : UAE NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)..233
TABLE NO. 264. : UAE NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million).234
TABLE NO. 265. : UAE NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million).234
TABLE NO. 266. : UAE NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………………235
TABLE NO. 267. : UAE NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………………235
TABLE NO. 268. : KSA NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)…236
TABLE NO. 269. : KSA NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)…236
TABLE NO. 270. : KSA NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million) .237
TABLE NO. 271. : KSA NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million) .237
TABLE NO. 272. : KSA NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………………238
TABLE NO. 273. : KSA NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………………238
TABLE NO. 274. : Israel NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million) 239
TABLE NO. 275. : Israel NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million) 239
TABLE NO. 276. : Israel NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million)240
TABLE NO. 277. : Israel NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million)240
TABLE NO. 278. : Israel NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………….241
TABLE NO. 279. : Israel NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………….241
TABLE NO. 280. : Turkey NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million)……………………………………………………………………………………………………………..242
TABLE NO. 281. : Turkey NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..242
TABLE NO. 282. : Turkey NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..243
TABLE NO. 283. : Turkey NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..243
TABLE NO. 284. : Turkey NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)…………..244
TABLE NO. 285. : Turkey NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)…………..244
TABLE NO. 286. : Iran NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million) ..245
TABLE NO. 287. : Iran NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million) ..245
TABLE NO. 288. : Iran NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD Million) .246
TABLE NO. 289. : Iran NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD Million) .246
TABLE NO. 290. : Iran NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………………247
TABLE NO. 291. : Iran NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………………247
TABLE NO. 292. : Rest of Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023
(USD Million)………………………………………………………………………………………………………248
TABLE NO. 293. : Rest of Middle East NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032
(USD Million)………………………………………………………………………………………………………248
TABLE NO. 294. : Rest of Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 –
2023 (USD Million)………………………………………………………………………………………………249
TABLE NO. 295. : Rest of Middle East NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 –
2032 (USD Million)………………………………………………………………………………………………249
TABLE NO. 296. : Rest of Middle East NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..250
TABLE NO. 297. : Rest of Middle East NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..250
TABLE NO. 298. : Africa NTM Diagnostic Market Revenue, By Country, 2018 – 2023 (USD Million) …………….253
TABLE NO. 299. : Africa NTM Diagnostic Market Revenue, By Country, 2024 – 2032 (USD Million) …………….253
TABLE NO. 300. : Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)254
TABLE NO. 301. : Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)254
TABLE NO. 302. : Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..255
TABLE NO. 303. : Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..255
TABLE NO. 304. : Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)……………256
TABLE NO. 305. : Africa NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)……………256
TABLE NO. 306. : South Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..257
TABLE NO. 307. : South Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..257
TABLE NO. 308. : South Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..258
TABLE NO. 309. : South Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..258
TABLE NO. 310. : South Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) …..259
TABLE NO. 311. : South Africa NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) …..259
TABLE NO. 312. : Egypt NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD Million)260
TABLE NO. 313. : Egypt NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD Million)260
TABLE NO. 314. : Egypt NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..261
TABLE NO. 315. : Egypt NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..261
TABLE NO. 316. : Egypt NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……………262
TABLE NO. 317. : Egypt NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……………262
TABLE NO. 318. : Algeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..263
TABLE NO. 319. : Algeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..263
TABLE NO. 320. : Algeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..264
TABLE NO. 321. : Algeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..264
TABLE NO. 322. : Algeria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ………….265
TABLE NO. 323. : Algeria NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ………….265
TABLE NO. 324. : Nigeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..266
TABLE NO. 325. : Nigeria NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..266
TABLE NO. 326. : Nigeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..267
TABLE NO. 327. : Nigeria NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..267
TABLE NO. 328. : Nigeria NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)………….268
TABLE NO. 329. : Nigeria NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)………….268
TABLE NO. 330. : Morocco NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..269
TABLE NO. 331. : Morocco NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..269
TABLE NO. 332. : Morocco NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..270
TABLE NO. 333. : Morocco NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..270
TABLE NO. 334. : Morocco NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million) ……….271
TABLE NO. 335. : Morocco NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million) ……….271
TABLE NO. 336. : Rest of Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..272
TABLE NO. 337. : Rest of Africa NTM Diagnostic Market Revenue, By Diagnostic Method, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..272
TABLE NO. 338. : Rest of Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2018 – 2023 (USD
Million) ……………………………………………………………………………………………………………..273
TABLE NO. 339. : Rest of Africa NTM Diagnostic Market Revenue, By NTM Infection Type, 2024 – 2032 (USD
Million) ……………………………………………………………………………………………………………..273
TABLE NO. 340. : Rest of Africa NTM Diagnostic Market Revenue, By End-user, 2018 – 2023 (USD Million)….274
TABLE NO. 341. : Rest of Africa NTM Diagnostic Market Revenue, By End-user, 2024 – 2032 (USD Million)….274

What is the current size of the Global NTM Diagnostic Market?

The Global NTM Diagnostic Market was valued at USD 1,814.8 million in 2023 and is projected to reach USD 3,261.1 million by 2032.

What factors are driving the growth of the Global NTM Diagnostic Market?

Growth is driven by the rising prevalence of NTM infections, advancements in molecular diagnostics, and increasing awareness among healthcare professionals.

What are the key segments within the Global NTM Diagnostic Market?

Key segments include diagnostic method (NAAT, PCR, immunological tests), infection type (pulmonary, cutaneous), and end-user (hospitals, laboratories).

What are some challenges faced by the Global NTM Diagnostic Market?

The market faces challenges such as high diagnostic costs, limited access in low-resource regions, and lack of standardized testing protocols.

Who are the major players in the Global NTM Diagnostic Market?

Major players include Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company (BD), and bioMérieux SA.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Gunakesh Parmar

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Related Reports By Keyword

Betamethasone Ointment Market

Published:
Report ID: 108686

Electronic Bill Presentment and Payment (EBPP) Market

Published:
Report ID: 12302

Dry Skin Cream Lotion and Ointment Market

Published:
Report ID: 75896

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

OTC Topical Antifungals Market

Published:
Report ID: 109720

Inbound Telemarketing Service Market

Published:
Report ID: 102573

Mobile Device Rental Platform Market

Published:
Report ID: 99456

Vernal Keratoconjunctivitis (VKC) Market

Published:
Report ID: 76996

Quality and Safety Reporting Systems Market

Published:
Report ID: 76661

Related Reports

Organoids in Regenerative Medicine Market

Published:
Report ID: 113353

Dull Skin Treatment Market

Published:
Report ID: 113281

Compound Pharmaceutical Packaging Market

Published:
Report ID: 113255

Vitamins, Minerals, and Supplements CDMO Market

Published:
Report ID: 99508

Drugs Glass Packaging Market

Published:
Report ID: 112886

Bipolar Disorder Mood Stabilizers Market

Published:
Report ID: 112620

Automated Insulin Delivery System Market

Published:
Report ID: 111962

Bacterial Conjunctivitis Market

Published:
Report ID: 7159

Advanced Wound Care Management Market

Published:
Report ID: 2599

Diabetic Ketoacidosis Treatment Market

Published:
Report ID: 72227

Fish Oil Based Drugs Market

Published:
Report ID: 111617

Patient Hygiene Aids Market

Published:
Report ID: 111668

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$12699

Let us help you

Credence Staff 3

WILLIAM, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

+64 22 017 0275

Kieran Jameson

KIERAN JAMESON, Australia

+61 4192 46279

Request Sample

Smallform of Sample request

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

[email protected]

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN

Request Sample